Filter
175
Text search:
organ
transplant
Featured
Recommendations
14
New Publications
44
Language
Document type
No document type
73
Guidelines
54
Studies & Reports
21
Manuals
8
Strategic & Response Plan
8
Fact sheets
4
Training Material
3
Brochures
2
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
25
Nigeria
8
Latin America and the Carribbean
8
South Africa
6
Philippines
5
Global
5
Zambia
4
Kenya
3
Western and Central Europe
3
Germany
2
Rwanda
2
Ukraine
2
Myanmar / Burma
2
Eastern Europe
2
USA
1
Ethiopia
1
Ghana
1
Nepal
1
Tanzania
1
Indonesia
1
Bangladesh
1
Namibia
1
Switzerland
1
Colombia
1
Bolivia
1
South–East Asia Region
1
Venezuela
1
Timor Leste/ East Timor
1
Russia
1
Belgium
1
Authors & Publishers
Publication Years
Category
Countries
69
Clinical Guidelines
29
Public Health
6
Key Resources
3
Women & Child Health
1
Toolboxes
NTDs
21
COVID-19
19
TB
18
AMR
8
Refugee
7
HIV
6
Caregiver
5
Pharmacy
4
NCDs
4
Conflict
3
Mental Health
3
Rapid Response
2
Zika
2
Planetary Health
2
Ebola & Marburg
1
Polio
1
Specific Hazards
1
Global Health Education
1
Social Ethics
1
Accessed Febr. 6, 2020
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ
...
Chagas disease is caused by Trypanosoma cruzi. Infection is transmitted to humans when bitten by Triatominae (reduviid, kissing, or assassin) bugs in South and Central America, Mexico, and very rarely in the US. Less commonly, T. cruzi is transmitted via ingestion of sugar cane juice or food contami
...
Antimicrobial resistance represents a big threat to public health. The Centers for Disease Control and Prevention (CDC) estimate that every year two million Americans are infected with a (multi-)drug resistant bacterium, resulting in 23,000 deaths. The WHO has repeatedly drawn attention to this majo
...
ISN Public Affairs Kidney International Supplements (2020) 10, e19–e23
La transmisión de T. cruzi de un donante con la enfermedad de Chagas a un receptor de trasplante es poco frecuente y es resultado de la aplicación de un tratamiento quirúrgido. En este documento se proponen diez pautas para manejar y prevenir la transmisión de la enfermedad de Chagas por traspla
...
PLoS Negl Trop Dis 13(10): e0007694. In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Developmen
...
Mass population movements have accounted for the emergence of Chagas disease (CD) outside endemic regions,
including the European Union/European Economic Area (EU/EEA). The parasite responsible for causing CD,
Trypanosoma cruzi (T. cruzi), can be transmitted through substances of human origin (SoH
...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t
...
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
Accessed Febr. 6, 2020
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali
...
Rev. Panam Salud Publica. 2017;41:e153. doi: 10.26633/RPSP.2017.153
Worldwide, over 6 million people are infected with Trypanosoma cruzi, the pathogen that causes Chagas disease (CD). In the Americas, CD creates the greatest burden in disability-adjusted life years of any parasitic infection. In Co
...
The Lancet Regional Health - Americas 2024;36: 100821 https://doi.org/10.1016/j.lana.2024.100821
Nature Medicine, https://doi.org/10.1038/s41591-021-01283-z
Clinical Infectious Diseases 2010; 50:291–322
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition
...
September 2021
Updated Treatment Guidelines
